Target intelligence / Profile preview

Lipopolysaccharide-containing Gram-negative outer membrane (LPS-containing GNOM)

Target
LPS-containing GNOM
Molecular classification
Other
01

Overview

The lipopolysaccharide-containing Gram-negative outer membrane is a highly asymmetric lipid bilayer that serves as the primary permeability barrier protecting Gram-negative bacteria from toxic environmental agents, including many classes of antibiotics. The outer leaflet of this membrane is composed almost entirely of lipopolysaccharide (LPS), a complex glycolipid whose lipid A component anchors the molecule and acts as a potent endotoxin. This unique structure restricts the passive diffusion of hydrophobic and large hydrophilic molecules, contributing significantly to the intrinsic multidrug resistance of Gram-negative pathogens. Therapeutic agents such as polymyxins target this membrane by electrostatically interacting with the negatively charged phosphate groups of LPS, displacing divalent cations, and physically disrupting membrane integrity to cause cell death. However, targeting this structure is associated with notable clinical challenges, including severe nephrotoxicity and neurotoxicity, as well as the potential for rapid endotoxin release leading to systemic inflammatory responses.

Other names
Gram-negative outer membraneLipopolysaccharide outer membrane leafletBacterial outer membraneLPS-containing outer membrane
02

Biological functions

Other
03

Disease associations

Infection
04

Safety considerations

NephrotoxicityNeurotoxicityNeuromuscular blockadeJarisch-Herxheimer reaction due to rapid endotoxin releaseDevelopment of resistance via lipid A modification
05

Interacting drugs

5 more in the full profile.

06

Biomarkers

Gram-negative bacterial cultureLipopolysaccharide levelsProcalcitoninC-reactive protein

Beyond the preview

Go deeper on Lipopolysaccharide-containing Gram-negative outer membrane (LPS-containing GNOM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide-containing Gram-negative outer membrane (LPS-containing GNOM).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call